Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery

PLN formulations have been demonstrated to increase drug loading efficiency, enable controlled drug release, improve drug uptake and intracellular drug transport, and circumvent membrane efflux transportermediated multidrug resistance (MDR) in cancer cells.